impact of excipients [Dissolution / BCS / IVIVC]

posted by luvblooms  – India, 2013-10-03 07:53 (4651 d 12:47 ago) – Posting: # 11592
Views: 6,309

Dear Dan

Agree to your point that there are

❝ an endless number of papers describing an impact of an excipient on a special drug substance.


And yes they cause confusion too.

Now coming to your point

❝ you do not know the exact quantitative composition of the reference and how to decide which difference would become significant and relevant?


How about doing reverse engineering? Try using NIR or some other method (some time chemical methods works too) to estimate the excipient quantitatively.

We have done it for one of the BCS class I drug for US and EU submission and did not faced much problem. (In that condition reference was having poloxamer and different amounts for US and EU, quantitative estimations helped)

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
369 visitors (0 registered, 369 guests [including 18 identified bots]).
Forum time: 20:41 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5